Alissa received her PhD in cancer research in 2018 and joined Redoxis in 2021 as a Project Leader. She brings strong scientific expertise and a solution-oriented mindset to every project, combining precision, dedication, and a structured approach to study execution.
At Redoxis, Alissa primarily leads in vivo studies, overseeing project planning, study execution, and data delivery across a range of preclinical disease models. She works closely with internal teams to ensure studies are conducted with high scientific quality and operational reliability.
With her adaptability, technical competence, and collaborative approach, Alissa plays an important role in delivering robust data and supporting successful client projects at Redoxis.
